Live Breaking News & Updates on Medicine Trading Down
Stay updated with breaking news from Medicine trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […] ....
Wedbush restated their outperform rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Monday morning, RTT News reports. The brokerage currently has a $43.00 target price on the stock, down from their prior target price of $84.00. Wedbush also issued estimates for Disc Medicine’s Q4 2024 earnings at […] ....
Prime Medicine, Inc. (NYSE:PRME – Get Free Report)’s stock price hit a new 52-week low on Friday . The company traded as low as $5.48 and last traded at $5.82, with a volume of 210141 shares traded. The stock had previously closed at $5.79. Wall Street Analysts Forecast Growth A number of research firms have […] ....
Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective cut by Morgan Stanley from $75.00 to $40.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 26.78% from the stock’s previous close. A […] ....
Prime Medicine (NYSE:PRME) Earns Outperform Rating from Analysts at Wedbush theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.